文献速递功能神经外科

深部脑刺激治疗难治性抑郁的不良反应:范围综述

Adverse Effects of Deep Brain Stimulation for Treatment-Resistant Depression: A Scoping Review.
PubMed 文献 · Neurosurgery · 2024-03-21

本范围综述遵循PRISMA指南检索PubMed,纳入28篇报告353例患者的文献,汇总深部脑刺激(DBS)治疗难治性抑郁(TRD)的安全性数据。出血发生率为0.8%,感染为10.2%,完成自杀率为2.5%,抑郁症状恶化、焦虑和躁狂的发生率分别为18.4%、9.1%和5.1%。作者结论认为DBS治疗TRD与手术及精神不良事件相关,考虑DBS时应知晓抑郁恶化、焦虑和躁狂的风险。

要点

  • DBS治疗TRD的出血发生率为0.8%,感染发生率为10.2%。
  • 完成自杀率为2.5%,抑郁症状恶化、焦虑和躁狂发生率分别为18.4%、9.1%和5.1%。
  • 不同靶点间存在差异,但研究间异质性妨碍了统计学比较。

核心结论

  • DBS治疗TRD与手术及精神不良事件相关。
  • 出血和感染的发生率在其他DBS应用的公认范围内。
  • DBS治疗TRD后自杀风险为2.5%,但可能并不代表显著偏离TRD的自然史。
  • 考虑DBS治疗TRD时,应知晓抑郁恶化、焦虑和躁狂发生风险。

研究设计与样本

  • 遵循PRISMA指南的范围综述,检索PubMed中描述DBS治疗TRD后不良结局的英文文章。
  • 纳入标准为报告至少5例患者且最短随访6个月的研究。
  • 经摘要筛选(n=607)和全文审阅(n=127)后,28篇文章报告353例患者符合最终纳入标准。
  • 所检索研究的随访时间为12至96个月。

主要发现

  • 出血发生于0.8%的患者,感染发生于10.2%的患者。
  • 完成自杀率为2.5%。
  • 抑郁症状出现或加重、焦虑和躁狂的发生率分别为18.4%、9.1%和5.1%。
  • 不同靶点之间存在一些差异,但研究间异质性妨碍了统计学比较。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究间异质性妨碍了统计学比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deep brain stimulation (DBS) is an emerging therapy for treatment-resistant depression (TRD). Although adverse effects have been reported in early-phase and a few randomized clinical trials, little is known about its overall safety profile, which has been assumed to be similar to that of DBS for movement disorders. The objective of this study was to pool existing safety data on DBS for TRD. Following PRISMA guidelines, PubMed was searched for English articles describing adverse outcomes after DBS for TRD. Studies were included if they reported at least 5 patients with a minimal follow-up of 6 months. After abstract (n = 607) and full-article review (n = 127), 28 articles reporting on 353 patients met criteria for final inclusion. Follow-up of the studies retrieved ranged from 12 to 96 months. Hemorrhages occurred in 0.8% of patients and infections in 10.2%. The rate of completed suicide was 2.5%. Development or worsening of depressive symptoms, anxiety, and mania occurred in 18.4%, 9.1%, and 5.1%, respectively. There were some differences between targets, but between-study heterogeneity precluded statistical comparisons. In conclusion, DBS for TRD is associated with surgical and psychiatric adverse events. Hemorrhage and infection occur at rates within an accepted range for other DBS applications. The risk of suicide after DBS for TRD is 2.5% but may not represent a significant deviation from the natural history of TRD. Finally, risks of worsening depression, anxiety, and the incidence of mania should be acknowledged when considering DBS for TRD.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Lapa JDS, Duarte JFS, Campos ACP, et al. Adverse Effects of Deep Brain Stimulation for Treatment-Resistant Depression: A Scoping Review. Neurosurgery. 2024. PMID: 38511957. doi:10.1227/neu.0000000000002910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。